Noteworthy Thursday Option Activity: AI, AMBA, MRTX Thursday, May 25, 4:47 PM ET, by Market News Video Staff Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...
Sum Up The Parts: IWB Could Be Worth $262 Monday, June 5, 7:55 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
Interesting MRTX Put And Call Options For July 21st Wednesday, June 7, 10:49 AM ET, by Market News Video Staff Investors in Mirati Therapeutics Inc (MRTX) saw new options become available this week, for the ...
Analysts Expect IYH To Hit $322 Thursday, July 6, 9:14 AM ET, by Market News Video Staff Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So in this series we look at the largest insider buys by company directors over the trailing six month period, one of which was a total of $300K by Faheem Hasnain, Director at Mirati Therapeutics Inc (NASDAQ:MRTX).
Hasnain bets big on MRTX:
Purchased
Insider
Title
Shares
Price/Share
Value
08/11/2023
Faheem Hasnain
Director
10,791
$27.80
$299,989.80
Hasnain's average cost works out to $27.80/share. Shares of Mirati Therapeutics Inc were changing hands at $37.65 at last check, trading down about 2.5% on Monday. The chart below shows the one year performance of MRTX shares, versus its 200 day moving average:
Looking at the chart above, MRTX's low point in its 52 week range is $27.30 per share, with $101.30 as the 52 week high point — that compares with a last trade of $37.65.
This Article's Word Cloud:BuysCompanyDaysDirectorDirectorsDollarsFaheemHasnainInsiderJoinLookingMRTXMiratiMondayOfferPresumablyPricePurchasedSevenShareSharesSpecialStartTherapeuticsTitleValueValueForumaboutaboveaveragebelowbetsbothbusinessbuyschartcompanydirectorslastmakemaybemdashpointsharestocktakethattheyweekwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.